Pain is inevitable. Suffering is optional. [Buddhist proverb]

The subject of pain is often in the news. This week (23 August 2019) we notice the St. Louis Business Journal carrying an article about the National Institutes of Health giving a $2.1 million grant to a St. Louis University pain researcher “to help open up a new avenue for pain medication research.”

We have a suspicion that the whole subject of pain is not understood very well by many people, so we thought we’d discuss it here.

What is Pain?

The first order of business should be a useful definition of pain. As is usual with many English words, there are multiple definitions of the word. Pain is a perception available to living beings.

English definitions: punishment; an unpleasant bodily sensation; physical discomfort; mental or emotional distress or suffering; something troublesome; a result of loss; a result of causing bad acts.
[Middle English, from Anglo-French peine, from Latin poena, from Greek poin? “payment, penalty”]

Technical definitions: Pain is the randomity (misalignment) produced by sudden or strong counter-efforts (i.e. efforts opposing optimum survival); the ultimate penalty of destructive activity; the warning of loss; the threat of non-survival; the punishment for errors in trying to survive.

Memories of pain can be just as damaging as the actual pain itself. Unconsciousness to greater or lesser degree is a symptom of pain. Unfortunately for humans, any sensation is better than no sensation; so in the absence of any sensation one desires pain.

Pain can be synthesized as an electronic flow. Psychiatrists use the pain of electroshock and other harmful psychiatric treatments as a coercive control mechanism — a means of getting someone to behave as they have decided one should behave. A person can be so overwhelmed by pain that they become addicted to it.

Painkillers

Doctors prescribe pain killers to relieve pain. However, it has never been known exactly how or why these “work.” Research into pain killers generally occurs by accidental discoveries, and the results often have undesirable side effects. The actions of pain killers include impeding the electrical conductivity of nerve channels, rendering a person unfeeling. Pain drugs block wanted sensations as well as unwanted ones.

Psychiatric Drugs

Psychiatric drugs are prescribed for various types of physical pain and mental trauma. Read the manufacturer’s fine print for any psychiatric drug and it will say in so many words that “we don’t really know how this drug works,” and they all have bad side effects; although one could say that there are no “side effects” since these are the actual effects of the drugs, albeit unwanted. It could be dangerous to immediately cease taking psychiatric drugs because of potential significant withdrawal side effects. No one should abruptly stop taking any psychiatric drug without the advice and assistance of a competent medical doctor.

Because of the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders (DSM-5), psychiatrists have deceived millions into thinking that the best answer to life’s many pains lies with the “latest and greatest” psychiatric drug. The DSM has led to the unnecessary drugging of millions of Americans who could be diagnosed, treated, and cured by non-psychiatric health care providers without the use of toxic and potentially lethal drugs.

Since psychiatric drugs do not actually cure conditions, but merely suppress symptoms, the patient may be lulled into a temporary sense of wellness; whatever condition has caused the symptom is still present and often growing worse.

A person in chronic physical pain may be misdiagnosed with a so-called mental disorder, labeled neurotic, and given a psychiatric drug which only makes the condition worse.

Authors Richard Hughes and Robert Brewin, in their book, The Tranquilizing of America, warned that although psychotropic drugs may appear “to ‘take the edge off’ anxiety, pain, and stress, they also take the edge off life itself … these pills not only numb the pain but numb the whole mind.”

Did we mention that the three Sackler brothers of Purdue Pharma, major enablers of the opioid addiction crisis, were all psychiatrists? A June 26, 2017 article on Kaiser Health News by Vickie Connor presents the information that, “Adults with a mental illness receive more than 50 percent of the 115 million opioid prescriptions in the United States annually.” We don’t really know which came first — the mental trauma or the physical pain; but it doesn’t really matter which comes first. The bottom line is that neither opioids nor psychiatric drugs are workable treatments.

What About the Suffering?

So how does one in pain overcome the suffering, as the ancient Buddhist proverb goes? Basically, understanding relieves suffering. We want you to understand that psychiatry kills. Find Out! Fight Back!

It’s All In Your Brain (Not!)

The Year of the Brain

President Obama announced The BRAIN Initiative (Brain Research through Advancing Innovative Neurotechnologies) on April 2, 2013. The White House wanted to spend $100 million taxpayer dollars in 2014 on brain research.

We had little faith that $100 million would be used for developing anything but more abusive psychiatric drugs or more torturous devices such as Vagus Nerve Stimulation or Transcranial Magnetic Stimulation.

The problem is that the biological brain drug model based on bogus mental disorders in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) prevents governments from funding real medical solutions for people experiencing difficulty.

Despite the billions of government and pharmaceutical company funding in support of psychiatry’s brain chemical imbalance theory, this psychiatric “disease” model has been thoroughly debunked. The whole theory was invented to push drugs for profit.

The Brain of the Year

But it’s not just a matter of psychiatric drugs. The entire psychiatric and psychological industries are oriented on the brain. They have a number of names for it: neuropsychology, neuropsychiatry, neurocomputation, neurological psychology, neurological psychiatry — it all just means that psychiatry and psychology, in another attempt to make their pseudosciences seem more scientific, have joined up with the legitimate neuroscience field, in another attempt to blame it all on the brain. You might as well just blame it on the Bossa Nova.

One research paper claims that perception is often biased, selective, and malleable, and it all happens in the brain with neural activity.

Granted, the brain does play a role in perception. The brain might even be fooled by a trompe l’oeil, a visual illusion. But if you buy in to the cry that “it’s all brain” then you have abandoned your humanity, and your spirit, in favor of chemistry; you have bought into the reductio ad absurdum argument that there is no objective reality, it’s all in your brain.

Of course, once the psychopharmaceutical industry gives all its attention to the brain, then the brain is miraculously transformed into the seat of consciousness, and altering consciousness with drugs becomes commonplace. And we get the disastrous psychedelic psychiatric movement, where magic mushrooms will lead you to a better life.

Apparently enough time has passed that the public has forgotten what happened when psychedelics gained notoriety in the 1960s, when LSD pushed by psychiatrists spread into society as a recreational drug and started destroying lives with induced psychosis.

Brain Dead

Knowing nothing about the underlying causes of serious mental disturbance, psychiatry still sears the brain with electroshock, tears it with psychosurgery and deadens it with dangerous drugs.

Next time you are told that a psychiatric condition is due to a biochemical imbalance in the brain, ask if you can see the lab test results. There won’t be any.

The true resolution of many mental difficulties begins, not with a checklist of symptoms, but with ensuring that a competent, non-psychiatric health care professional completes a thorough physical examination.

If It’s Not The Brain, What Is It?

Rather than get all metaphysical, let’s just observe that for many questions, there is not just one answer. That’s a particularly relevant observation for psychiatric, brain and drug based research — the search for the One Thing that answers “Why did this happen?” This attitude only leads to a list of things, a list of symptoms, say, in the DSM.

Using the DSM, a psychiatrist need only label the patient with a single “mental disorder”, prescribe a drug and bill the patient’s insurance. The psychiatrist with the DSM in hand can try various diagnostic labels on the patient as if they were different sizes of apparel until he finds one that either fits the patient’s symptoms or comes close enough to allow him to bill the patient’s insurance. It’s the One Answer, you see, to all the patient’s problems. At least, it’s the only one needed to submit an insurance claim.

But the question, “Why is the patient behaving this way?” does not have just one answer; it can have many, many answers.

Let’s give an example, the classic Country Blues one.
Question: “Why do I feel so blue?”
Answer: My dog ran away. My wife left me. My husband left me. (We’re not sexist here.) My truck died. I’m broke. I’m broken hearted. I’ve been betrayed. No one really cares. No one ever listens to me. I did you wrong and now you’re gone.

You see, there’s more than one answer, and it isn’t “you’re depressed and need to take an antidepressant.”

It wasn’t the brain, you see. It was the dog, the wife, and the truck. It all piled on until the stress of it overwhelmed. You get the idea.

So what is the resolution of mental trauma? Well, each answer would have it’s own resolution. Get another dog, get another wife, get another truck, listen to others so they listen to you. Whatever it takes. You get the idea, again. An antidepressant makes the feeling go away, for a time (it makes ALL feelings go away, the good and the bad); but the dog is still gone, the wife is still gone, and the truck is still broken. And you can be sure your psychiatrist isn’t listening to you, except to hear for which DSM symptom he can prescribe a drug and bill your insurance.

So of course one’s perception can be biased, selective and malleable. It isn’t, however, the brain. It’s Life. Get Over It!

More About Psychiatric Drugs Causing Violence and Suicide

Reference:

Antidepressant-induced akathisia-related homicides associated with diminishing mutations in metabolizing genes of the CYP450 family
by Yolande Lucire and Christopher Crotty
Pharmacogenomics and Personalized Medicine, 1 August 2011
[doi: 10.2147/PGPM.S17445]

This research paper details patients who had been referred to Dr. Lucire’s practice for expert opinion or treatment. More than 120 subjects were diagnosed with akathisia [a neurotoxic psychosis often characterized by a feeling of inner restlessness and inability to stay still] or serotonin toxicity [extremely high levels of serotonin causing toxic and potentially fatal effects] after taking psychiatric drugs that had been prescribed for psychosocial distress. Akathisia has been known to be associated with suicide since the 1950s and with homicide since 1985.

They were tested for variant alleles in cytochrome P450 (CYP450) genes, which play a major role in the metabolism of all antidepressant and many other drugs, indicating ultrarapid metabolism due to allele duplications. This seems to be strongly associated with a large number of deaths from intoxication and suicide. High or fast-changing levels of psychotropic substances can cause unpredictable toxicity leading to violent behavioral effects, including akathisia. [An allele is one of two or more alternative forms of a gene that arise by mutation and are found at the same place on a chromosome.]

Psychiatric drugs are metabolized in the liver by cytochrome P450 enzymes in order to be eliminated from the body. Abnormal CYP450 metabolism, either ultrarapid and/or diminished, can lead to the drug or its metabolites reaching a toxic level in hours or days, correlating with the onset of intense dysphoria [unease or generalized dissatisfaction with life] and akathisia. A person genetically deficient in these enzymes, or who has an ultrarapid drug metabolism, or who is taking other (legal or illegal) drugs that diminish CYP450 enzyme activity, is at risk of a toxic accumulation of the drug leading to more severe side effects.

Eight of these cases had committed homicide and many more became extremely violent or suicidal while on antidepressants. Ten representative case histories involving serious violence are presented in great detail in the paper. None of the ten subjects described had any history of mental illness; none had been violent before. All recovered from akathisia after stopping the medication without assistance or supervision and, frequently, against medical advice.

Akathisia suicides and homicides, particularly when they involved children, gave rise to the first antidepressant suicide advisories by the FDA in 2004.

Personal, medical, and legal problems can arise from using psychiatric drugs and experiencing the resulting toxicity from these metabolic effects. The results presented in this paper demonstrate the grave extent to which the psychiatric industry has expanded its influence beyond its ability to cure.

As the authors state, “In all of the cases presented here, the subjects were prescribed antidepressants that failed to mitigate distress emerging from their predicaments, which encompassed psychosocial stressors such as bereavement, marital and relationship difficulties, and work-related stress. Every subject’s emotional reaction worsened while their prescribing physicians continued the “trial and error” approach, increasing from standard to higher dose and/or switching to other antidepressants, with disastrous consequences. In some cases the violence ensued from changes occasioned by withdrawal and polypharmacy. In all of these cases, the subjects were put into a state of drug-induced toxicity manifesting as akathisia, which resolved only upon discontinuation of the antidepressant drugs.”

“It is the authors’ contention that prescribing antidepressants without knowing about CYP450 genotypes is like giving blood transfusions without matching for ABO groups [the classification of human blood].”

In general, the psychiatric industry pushes psychotropic drugs without regard to these CYP450 cautions, but this is the direct result of the unscientific psychiatric diagnoses perpetrated by the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) which fraudulently justifies prescribing these harmful drugs for profit in the first place.

Recommendations

1. Practice Full Informed Consent by asking your doctor for information about possible side effects and benefits, ways to treat side effects, and risks of other conditions, as well as information about alternative treatments.

2. If your doctor diagnoses a mental disorder and prescribes a psychiatric drug, ask to see the clinical lab tests proving the diagnosis. (There won’t be any.)

3. All treatment options should include checking for real underlying medical conditions that could cause a patient’s mental or emotional duress.

4. Write your state and federal legislators to establish rights for patients and their insurance companies to receive refunds for mental health treatment which did not achieve the promised result or improvement, or which resulted in proven harm to the individual, thereby ensuring that responsibility lies with the individual practitioner and psychiatric facility rather than the government or its agencies.

5. The Diagnostic and Statistical Manual of Mental Disorders (DSM-5), psychiatry’s billing manual for mental disorders, is the key to false escalating mental illness statistics and psychiatric drug prescriptions and usage worldwide. Untold harm and colossal waste of mental health funds occur because of it. It is imperative that the DSM diagnostic system be abandoned before real mental health reform can occur.

6. Patients, doctors and insurance companies should report all instances of adverse side effects from psychiatric drugs to the FDA.

7. The pernicious influence of psychiatry has wreaked havoc throughout society, especially in hospitals, educational systems and prisons. Citizens groups and responsible government officials should work together to expose and abolish psychiatry’s hidden manipulation of society for profit.

Psychiatrists Anxious to Treat All Child-bearing Women for Post-Partum Depression

The FDA approved the first drug treatment for post-partum depression (PPD) on March 19, 2019. Psychiatrists call this “peripartum depression”, which means depressive symptoms during pregnancy or after childbirth. While there is no  actual diagnostic test for this, the current revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) labels this with various alternative wordings of “depressive disorder” or “bipolar disorder” or “anxiety disorder” or “stress disorder,” sometimes with the specifier “with peripartum onset“, depending on the circumstances.

The diagnosis is totally subjective, and is a justification for making money for prescribing an antidepressant. Psychiatrists do not typically perform any clinical tests to find out if there is a real medical reason for the symptoms, such as thyroid problems or vitamin deficiencies. Research suggests that rapid changes in hormones and thyroid levels during and after delivery have a strong effect on moods, yet this is mostly ignored by the psychiatric industry since it is easier and more profitable to prescribe a psychotropic drug.

The drug is Zulresso (generic brexanolone), an intravenous infusion administered continuously over 60 hours (2.5 days) and requiring constant monitoring. There is a risk of serious harm due to a sudden loss of consciousness during the treatment, the appearance of suicidal thoughts and behaviors, or hypoxia (loss of oxygen in the blood). The drug passes into breast milk, but there is no data on the safety of brexanolone while breastfeeding. The cost has currently been set at $34,000 per course of treatment.

Sage Therapeutics says that this neurosteroid, a derivative of allopregnanolone, affects GABAA (Type-A gamma-Aminobutyric acid) neurotransmitter receptors in the brain, although the actual mechanism of action of this drug with respect to PPD (or any other condition) is unknown.

Many people think that post-partum depression is a mental illness. However, this is very misleading for a mother who has experienced the trauma of just giving birth. To have them think the emotional roller coaster they may be experiencing is the result of a “chemical imbalance in the brain,” requiring mind-altering medication, is false and potentially very harmful.

This does not mean that serious emotional difficulties do not exist. But it does mean that psychiatrists and psychologists have used such difficulties to their advantage, promoting powerful drugs as a “solution” for vulnerable individuals. This has been for the sake of profit, often at the expense of people’s lives.

Quite apart from such drugs causing harm, they are also unnecessary. Any competent medical doctor who takes the time to conduct a thorough physical examination of someone exhibiting signs of what psychiatrists say are “mental disorders,” including post-partum depression, can find undiagnosed, untreated physical conditions.

Instead, psychiatrists prefer to tell young mothers that their condition is an “illness,” requiring “medication,” potentially endangering the life of the mother and her child.

Women may experience drastic drops in hormone levels after the birth of a child that can deliver a major shock to the woman’s body. Nutritional and mineral depletion or deficiencies as well as a lack of sleep while caring for a baby can also cause the symptoms psychiatrists say are a “mental disorder.” It can be treated nutritionally.

For more information, download and read the CCHR bookletThe Drugging of ‘Post Partum Depression’ – Clearing up Misconceptions About ‘Chemical Imbalances,’ Antidepressant Drugs and Non-Drug Solutions“.

You’re Not Paranoid, It’s Really Happening

Abilify Mycite® (aripiprazole tablets with sensor, from Otsuka Pharmaceutical) is a prescription drug of an aripiprazole tablet (an atypical antipsychotic) with a metallic Ingestible Event Marker (IEM) sensor inside it, used in adults for diagnoses of schizophrenia, bipolar I disorder, and major depressive disorder. A month’s supply of it costs around $1,650. The actual mechanism of action of aripiprazole is unknown, although it messes with the levels of dopamine and serotonin in the brain, which is playing Russian Roulette with your mind.

The sensor is intended to track, with a smartphone app, if the drug has been taken. The ability of this drug to improve patient compliance or modify dosage has not been established. The only thing the FDA approved was functions related to tracking drug ingestion. The use of this drug to track drug ingestion in real-time or during an emergency is not recommended because detection may be delayed or not occur.

The drug sends information to a patch worn on the patient’s arm, which is then logged on a mobile app, which then sends the data to their doctor. Some experts warn that the idea of swallowing a tracking chip may be too much for paranoid patients to handle.

Said one expert, “I am concerned about the formation of new pharmaceutical persons who are digitally enhanced to be compliant with the profit motives of corporations and the directives of health providers and drug companies. … The fact that the drug is Abilify, which is prescribed to people who experience serious mental distress, should raise many ethical red flags. These concerns are especially relevant because the patent for the original Abilify drug expired in 2016… My concern is that … the company will be motivated to profit from the technology as much as possible, regardless of whether the drug actually improves health.”

The idea for this gross invasion of privacy comes about because refusing to take prescribed drugs is a particular psychiatric concern, and is even enshrined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) as “Nonadherence to medical treatment.”

Abilify MyCite is still not widely used in the US, possibly because of skepticism from patients, prescribing doctors and insurance providers, although Otsuka has collaborated with Magellan Health to roll the drug out to the US, and UnitedHealthcare has developed complex rules for insurance authorization.

This drug has potentially severe side effects including stroke; akathisia; neuroleptic malignant syndrome; tardive dyskinesia; unusual urges such as compulsive gambling, sex, eating, or shopping; seizures; suicidal thoughts or behaviors. Side effects may be considerably more severe with known CYP2D6 poor metabolizers (a Cytochrome P450 enzyme.)

This drug also has a Boxed Warning about an increased risk of suicidal thinking and behavior in children, adolescents and young adults.

Recognize that the real problem is that psychiatrists fraudulently diagnose life’s problems as an “illness”, and stigmatize unwanted behavior as “diseases.” Psychiatry’s stigmatizing labels, programs and treatments are harmful junk science; their diagnoses of “mental disorders” are a hoax — unscientific, fraudulent and harmful.

If you are taking this drug, do not stop suddenly. You could suffer serious withdrawal symptoms. You should seek the advice and help of a competent medical doctor or practitioner before trying to come off any psychiatric drug.

Set It and Forget It Birth Control

We’ve recently been seeing frequent TV ads for Kyleena and Mirena, intrauterine devices (IUDs) that slowly release a progestin hormone called levonorgestrel into the uterus to prevent pregnancy, sometimes referred to as “Set it and forget it birth control.”

Interestingly enough, the manufacturer of levonorgestrel tablet contraceptives (Plan B) says “This medication is an emergency contraceptive and should not be used as a regular form of birth control.”

Possible adverse side effects from these IUD devices include ovarian cysts, abdominal/pelvic pain, headache or migraine, acne, breast tenderness or pain, heavier bleeding, depression, changes in hair growth, and hair loss.

The potential for depression as a side effect caught our attention.

Then the May 2019 Scientific American was published with several articles about birth control, indicating that the occurrence of bad side effects from IUDs are much higher than one might suspect.

One article brought it even closer to our home, saying that “Much of the recent enthusiasm over IUDs can be traced back to a single study called the Contraceptive CHOICE research project [2007-2011]. Funded in part by a then anonymous donor now known to be the Susan Thompson Buffett Foundation and facilitated by Washington University in St. Louis, the project had the explicit goal of increasing the use of LARC [Long-Acting Reversible Contraception] among women at high risk of unintended pregnancy.”

Obviously we are not advocating for or against anything related to birth control; our sole interest is in how the psychiatric industry may be involved. And with depression as a side effect of these devices, we have a clue.

We’ve all heard the term Premenstrual Syndrome (PMS), which includes symptoms such as mood swings, irritability and depression. Current thinking is that over 90% of women get some PMS adverse side effects.

Naturally, if psychiatrists can prescribe a drug for it, they will include it in the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) so that insurance will pay for diagnosing it and prescribing a drug.

So what does the DSM have to say about it? Here are some possible related diagnoses:

— Premenstrual dysphoric disorder [dysphoric means “a state of unease or dissatisfaction”]
— Problems related to unwanted pregnancy
— Depressive disorder due to another medical condition
— Unspecified depressive disorder
plus another 75 disorders related to depression of one kind or another.

All of these fraudulent diagnoses can be used to prescribe an antidepressant or some other harmful and addictive psychiatric drug, none of which actually address the root cause of the condition.

Need we actually say that premenstrual dysphoric disorder, or PMS, is not a “mental illness” requiring an antidepressant? Need we actually say that a depressive side effect of an IUD is not a “mental illness” requiring an antidepressant?

Well, we’ve said it anyway. Protect yourself from psychiatric fraud and abuse by insisting on Full Informed Consent with your doctor.

Shock and Awe – the Latest Psychiatric Abuse of Children

Shock and Awe is a tactic based on the use of overwhelming power and spectacular displays of force to paralyze an enemy.

Now the psychiatric industry is introducing electrical “stimulation” of children’s brains as a socially acceptable gradient to just plain shocking them into good behavior.

The U.S. Food and Drug Administration (FDA) approved on April 19, 2019 a medical device for so-called attention deficit hyperactivity disorder (ADHD). The prescription-only device, called the Monarch external Trigeminal Nerve Stimulation (eTNS) System from NeuroSigma, is for patients ages 7 to 12 years old who are not currently taking prescription ADHD drugs. It was originally developed at the University of California, Los Angeles, to reduce epileptic seizures. Research continues on using eTNS for epilepsy, depression, migraine, PTSD, and ADHD.

This device delivers an electric current to the brain (through the V1 branch of the 5th cranial nerve) with an electrode taped to the forehead. It costs about $900 to start, with additional costs for more of the electrode patches which are only used once each. It is not currently reimbursed by insurance.

While the exact mechanism of how eTNS is supposed to work is not known, one physical effect is apparently to increase blood flow in certain areas of the brain and decrease it in others. They recommend using it daily for up to four weeks before any significant changes are observed; we could not find any information about long-term effects or whether any changes are observed after treatment is stopped. It was clinically tested in 2017 in the U.S. for this FDA approval, paid for by a grant from the U.S. National Institute of Mental Health, on 62 children for four weeks. The most common side effects observed were drowsiness, an increase in appetite, trouble sleeping, teeth clenching, headache and fatigue.

Results were recorded during clinical testing by asking the child to answer questions on the ADHD Rating Scale (ADHD-RS) such as whether they have difficulty paying attention or regularly interrupt others. Ratings of ADHD symptoms on various rating scales are entirely subjective, as are the diagnostic criteria for ADHD.

A prior feasibility study in 2015 was performed with 24 children for 8 weeks, using the ADHD-IV Rating Scale. It did not establish the durability of treatment effects following discontinuation of treatment, either.

To be blunt, ADHD is a fraudulent “disease.” In 1987, ADHD was literally voted into existence by a show of hands of American Psychiatric Association members and included in the Diagnostic and Statistical Manual of Mental Disorders (DSM-V). Within a year, 500,000 children in America alone were diagnosed with this, and to expand the client base it has also been associated with Asperger syndrome and Autism spectrum disorder.

ADHD actually represents the spontaneous behaviors of normal children. When these behaviors become age-inappropriate, excessive or disruptive, the potential causes are limitless, including: boredom, poor teaching, inconsistent discipline at home, reading difficulty, tiredness, street drugs, nutritional deficiency, toxic overload, bullying, abuse, stress, and many kinds of underlying physical illness.

By making an ADHD diagnosis, we ignore and stop looking for what is really going on with the child. These children need the adults in their lives to give them additional attention and to find and treat the actual causes, rather than shock their brains to see if that “works.”

There are no workable ADHD drugs, either for children or for adults. This new “treatment” is supposed to be appealing because it does not use drugs, but guess what? They don’t know how it is supposed to work, either; and they haven’t tested it long enough to know the consequences of running an electric current into a child’s brain.

Aw shucks, no one denies that children can have difficult problems in their lives. Mental health care is therefore both valid and necessary. However, the emphasis must be on workable mental healing methods that improve and strengthen them by restoring personal strength, ability, competence, confidence, stability, responsibility and spiritual well-being. Psychiatric treatments are not workable; they are designed, with shock and awe, to overwhelm.

Chanting the Chantix Mantra

Recently there has been a gross increase in the TV ad campaign for Chantix, promoting this deadly drug for smoking cessation.

We’ve written about Chantix before, but we thought a repeat was in order due to this massive ad campaign.

In 2008 the Federal Aviation Administration banned Chantix for pilots and air traffic controllers, and reissued that decision in 2013.

The U.S. Food and Drug Administration (FDA) slapped a “Black Box” warning on Chantix (varenicline tartrate, made by Pfizer) in 2009 after receiving thousands of reports linking the drug to mental health issues, including suicidal thoughts, hostility and agitation.

In 2015, the FDA expanded the warning to note that the drug had also been linked to reduced alcohol tolerance leading to seizures.

However, in 2016 the FDA removed the Black Box warning, after heavy lobbying from Pfizer claiming that additional data showed that the benefits of Chantix outweighed its adverse side effects (oh, and since its sales had significantly dropped.)

But the adverse side effects did not go away; only the Black Box warning went away. One study found that Chantix had more cases of suicidal thoughts, self-harm, and homicidal thoughts than any other drug, by a more than three-fold margin. Pfizer’s prescribing information still warns about new or worsening mental health problems such as changes in behavior or thinking, aggression, hostility, agitation, depressed mood, or suicidal thoughts or actions while taking or after stopping Chantix.

We suspect that the recent spate of TV ads is related to the removal of the Black Box warning and the prior drop in sales. Also, the price of Chantix more than doubled between 2013 and 2018. In 2013, Pfizer paid out $273 million to settle a majority of the 2,700 state and federal lawsuits that had been filed over adverse side effects. Now the company is trying to grow the market with clinical studies for smokers age 12 to 19.

What is Chantix?

Chantix is a psychiatric drug — a benzodiazepine-based anti-anxiety drug, also called a minor tranquilizer or sedative hypnotic. Daily use of therapeutic doses of benzodiazepines are associated with physical dependence, and addiction can occur after 14 days of regular use. Typical consequences of withdrawal are anxiety, depression, sweating, cramps, nausea, psychotic reactions and seizures. There is also a “rebound effect” where the individual experiences even worse symptoms than they started with as a result of chemical dependency.

The exact mechanism of action of benzodiazepines is not known, but they affect neurotransmitters in the brain and suppress the activity of nerves, under the unproven theory that excessive activity of nerves may be the cause of anxiety. Chantix was developed to specifically affect nicotinic receptors in the brain, under the theory that this would reduce nicotine craving and block the rewarding effects of smoking. Messing with neurotransmitters in the brain is playing Russian Roulette with your mind.

Benzodiazepines are metabolized by cytochrome P450 enzymes, so a genetic lack of these enzymes can cause a buildup of harmful toxins and increase the severity of adverse side effects.

Psychiatric “best practices” consider that smoking is an addiction and recommend that psychiatrists assess tobacco use at every patient visit, since tobacco addiction is covered in the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) as a “mental illness” under eight separate items, and disorders related to inhalant use have 33 entries. Smoking is not a mental illness and addiction cannot be fixed with psychiatric drugs.

The psychiatric industry considers that smoking cessation therapies are their territory, however this drug masks the real cause of problems in life and debilitates the individual, thus denying one the opportunity for real recovery and hope for the future. Treating substance abuse with drugs is a major policy blunder; contact your state and federal representatives and let them know you disapprove of this trend.

Recognize that the real problem is that psychiatrists fraudulently diagnose life’s problems as an “illness”, and stigmatize unwanted behavior like smoking as a “disease.” Psychiatry’s stigmatizing labels, programs and treatments are harmful junk science; their diagnoses of “mental disorders” are a hoax — unscientific, fraudulent and harmful. All psychiatric treatments, not just psychiatric drugs, are dangerous.

Depression and The Marketing of Madness

The high-income partnership between psychiatry and drug companies has created an $80 billion psychotropic drug profit center, requiring constant marketing to push harmful and addictive psychotropic drugs on a vulnerable public.

How did psychotropic drugs, with no target illness, no known curative powers and a long and extensive list of harmful side effects, become the go-to treatment for every kind of psychological distress? And how did the psychiatrists espousing these drugs come to dominate the field of mental treatment?

Clever marketing hides the harm in a succession of consumer ads constantly churning through “new revelations.”

The most recent we’ve seen have been these gems:

— A new marketing catchphrase is being used in a Trintellix commercial — “Depression is multiple symptoms.”

— Another new marketing catchphrase is being used in a Latuda commercial — “A different type of depression.”

Psychiatry continues heavily pushing false data about depression

The fact is, the American Psychiatric Association, the American Medical Association and the National Institute of Mental Health admit that there are no medical tests to confirm depression as a disease but do nothing to counter the false idea that these are biological/medical conditions when in fact, diagnosis is simply done by a checklist of behaviors.

There are 77 entries in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) using some variation of the word “depressive”, so that nearly anyone can be so diagnosed and prescribed harmful and addictive psychotropic drugs.

Yes, people experience various symptoms of mental distress. This does not make them “mentally diseased” and there is no evidence of physical/medical abnormality for the so-called diagnosis of “depression.” This doesn’t mean that there aren’t solutions for people experiencing difficulty; there are non harmful, medical alternatives. But they do not require a psychiatric “label” to treat them. There is no mental illness test that is scientifically/medically proven. This isn’t a matter of opinion — psychiatrists who are opposed to the labeling of behaviors as mental illness openly admit this.

Dr. Thomas Szasz said, “The term ‘mental illness’ refers to the undesirable thoughts, feelings, and behaviors of persons.” More properly, it is just what psychiatry and psychiatrists have inappropriately labeled as “undesirable behavior;” the prime undesirable antisocial people on the planet telling you what they think is undesirable!

Find out more about the fake “disease” called depression and the harm that anti-depressive drugs do.

Watch the documentary exposing the truth behind the slick marketing schemes and scientific deceit that conceal a dangerous and often deadly sales campaign.

The Marketing of Madness Education Package is the ultimate resource for educating others on the dangerous effects of psychotropic drugs, and the multi-billion-dollar psychiatric-pharmaceutical partnership now dominating the field of mental health. CCHR is offering this kit for free to educators and lecturers to assist them in educating others about the risks of these mind-altering drugs, and to furnish information that is generally not told to patients or physicians. Arm yourself with the facts about psychiatry.

Buds Worth Billions – Blinded by the Buds

The January 18-24 2019 edition of the St. Louis Business Journal extolled the virtues of making lots of money from medical marijuana.

Yes, we know that medical marijuana is now legal in Missouri; and yes, we know that the Business Journal‘s interest in local businesses motivates its attention.

On the other hand, a convincing argument can be made that, while legal and profitable, promoting marijuana is decidedly unethical.

“The Missouri Medical Cannabis Trade Association estimates $500 million in total economic benefit for the first year of the program.”

There are countless arguments for “medical benefits”; but those arguments seem to take second place after the arguments for how much money can be made.

There are also arguments for medical harm. Let’s take a look at the medical disadvantages, to get a sense of how promoting marijuana could be unethical.

Marijuana is a Drug

Make no mistake, marijuana (often called cannabis in an attempt to avoid the negative connotations of weed) is a drug.

Regardless of the name, this drug is a hallucinogen — a substance which distorts how the mind perceives the world.

THC (tetrahydrocannabinol), the principal psychoactive component of marijuana, stays in the body for weeks, possibly months, depending on the length and intensity of usage. THC damages the immune system. In 2005, 242,200 emergency room visits in the U.S. involved marijuana. Nationwide, 40% of adult males tested positive for marijuana at the time of their arrest for a crime. Multiple studies have linked years of heavy marijuana use to brain abnormalities and psychosis. Cannabis is one of the few drugs which causes abnormal cell division which leads to severe hereditary defects.

Because a tolerance builds up, marijuana can lead users to consume stronger drugs to achieve the same effects.

People take drugs to get rid of unwanted situations or feelings. The drug masks the problem for a time, but when the “high” fades, the problem, unwanted condition or situation returns more intensely than before. Marijuana can harm a person’s memory — and this impact can last for days or weeks. Marijuana smoke also has all of the detrimental effects previously attributed to tobacco.

The use of marijuana is not only harmful to the person himself; he can also become a risk to society. Research clearly shows that marijuana has the potential to seriously diminish attention, memory, and learning. Users have more accidents, more injuries, and absenteeism than non-users.

Some will tell you that CBD (cannabidiol) is harmless because it does not contain THC. However, note that CBD and THC are structural isomers, which means they share the same chemical composition but their atomic arrangements differ. The proponents of CBD ignore the fact that it messes with the neurotransmitter serotonin when making claims for its safety and usefulness. There are very little long-term safety data available, but there is a lot of money riding on making this legal and ubiquitous; any bad effects are not going to be advertised or promoted. At higher dosages, CBD will deactivate cytochrome P450 enzymes, making it harder to metabolize certain drugs and toxins, particularly psychiatric drugs, leading to a toxic build-up of drugs and their subsequent adverse side effects.

How Drugs Work in the Body

Drugs are essentially poisons. The amount taken determines the effect. A small amount acts as a stimulant. A greater amount acts as a sedative. An even larger amount poisons and can kill. This is true of any drug.

Drugs block off all sensations, the desirable ones along with the unwanted ones. While providing short-term help in the relief of pain, they also wipe out ability and alertness and muddy one’s thinking.

Drugs affect the mind and destroy creativity. Drug residues lodge in the fatty tissues of the body and stay there, continuing to adversely affect the individual long after the effect of the drug has apparently worn off.

The Psychiatric Connection

In 2013 the American Psychiatric Association said, “There is no current scientific evidence that marijuana is in any way beneficial for the treatment of any psychiatric disorder.” The research was starting to show significant harm from cannabis use.

However, the psychiatric industry today has jumped on the cannabis bandwagon for several reasons. Psychiatrists are embracing all things marijuana because they are getting so many patients with marijuana-related problems such as addiction and psychosis. Marijuana addiction is such a significant problem that there are 31 entries in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) related to this addiction. Unfortunately, the last thing any psychiatric treatment has achieved is rehabilitation from addiction.

Since the 1950’s, psychiatry has monopolized the field of drug rehabilitation research and treatments. Its long list of failed cures has included lobotomies, insulin shock, psychoanalysis and LSD.

To the psychiatric industry, when they are not prescribing it as a “treatment”, cannabis use merely represents another pool of potential patients for other coercive and harmful treatments.

The history of psychiatry makes it clear that over many, many years they have been pushing dangerous drugs as “medicines.” We didn’t originally know about the long-term destructive effects of LSD, heroin, ecstasy, benzodiazepines, ritalin, and so on when psychiatrists first pushed them onto an unsuspecting society. Cannabis is no exception, as more and more psychiatrists are prescribing “medical” cannabis in spite of (or because of) the addiction problem. We think it’s the latter; the pool of potential psychiatric patients is increased by increasing cannabis use.

The Ethics of Promoting Marijuana Use

Ethics consists simply of the actions an individual takes on himself. A high level of ethics enhances one’s survival across all areas of life; it embodies rationality towards the greatest good for the greatest number. A low level of ethics, on the other hand, would be one’s irrationality toward bringing minimal survival, maximum harm or destruction, across all areas of life — or the least good for the fewest. An individual whose actions are harmful in society becomes subject to Justice. We leave it to each individual to observe for themselves the degree to which they and their associates are surviving well or poorly, and how marijuana may contribute to or obstruct the quality of their life.

In a statement issued January 13, 2019, the Cleveland Clinic announced that it will not be recommending medical marijuana to its patients. Dr. Paul Terpeluk, medical director of employee health services at the Cleveland Clinic, said, “There is little verified, published research that supports marijuana…as a medical treatment. … However, there is a significant amount of scientific literature that unequivocally shows that marijuana use has both short- and long-term deleterious effects on physical health.”

There are alternatives. We urge everyone embarking on some course of treatment to do their due diligence and undertake full informed consent.